Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1306-1315

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orth, M.
Right arrow Articles by Luley, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orth, M.
Right arrow Articles by Luley, C.
Related Collections
Right arrow Pathophysiology
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1306-1315.)
© 1999 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Effects of a Frequent Apolipoprotein E Isoform, ApoE4Freiburg (Leu28->Pro), on Lipoproteins and the Prevalence of Coronary Artery Disease in Whites

Matthias Orth; Wei Weng; Harald Funke; Armin Steinmetz; Gerd Assmann; Matthias Nauck; Jutta Dierkes; Andreas Ambrosch; Karl H. Weisgraber; Robert W. Mahley; Heinrich Wieland; Claus Luley

From the Institut für Klinische Chemie und Pathobiochemie, Universität Magdeburg (M.O., J.D., A.A., C.L.), Institut für Klinische Chemie und Laboratoriumsmedizin, Universität Münster (W.W., H.F., G.A.), Abteilung für Endokrinologie und Stoffwechsel, Universität Marburg (A.S.), and Abteilung für Klinische Chemie, Universität Freiburg, Germany (M.O., M.N., H.W., C.L.); Gladstone Institute of Cardiovascular Disease, San Francisco (M.O., K.H.W., R.W.M.), Cardiovascular Research Institute (M.O., K.H.W., R.W.M.), and Departments of Medicine (R.W.M.) and Pathology (K.H.W., R.W.M.), University of California, San Francisco. Current address for Wei Wang Laboratory of Biochemical Genetics and Metabolism, The Rockefeller University, New York, NY 10021-6399.

Correspondence to Dr Matthias Orth, Universitätsklinikum Benjamin Franklin, Freie Universität, Institut für Klinische Chemie und Pathobiochemie (WE 13), Hindenburgdamm 30, D-12220 Berlin, Germany. E-mail orth{at}ukbf.fu-berlin.de

Abstract—Different isoforms of apoE modulate the concentrations of plasma lipoproteins and the risk for atherosclerosis. A novel apoE isoform, apoE4Freiburg, was detected in plasma by isoelectric focusing because its isoelectric point is slightly more acidic than that of apoE4. ApoE4Freiburg results from a base exchange in the APOE4 gene that causes the replacement of a leucine by a proline at position 28. Analysis of the allelic frequencies in whites in southwestern Germany revealed that this isoform is frequent among control subjects (10:4264 alleles) and is even more frequent in patients with coronary artery disease (21:2874 alleles; P=0.004; adjusted odds ratio, 3.09; 95% confidence interval, 1.20 to 7.97). ApoE4Freiburg affects serum lipoproteins by lowering cholesterol, apoB, and apoA-I compared with apoE4 (P<0.05). Our 4 apoE4Freiburg homozygotes suffered from various phenotypes of hyperlipoproteinemia (types IIa, IIb, IV, and V). In vitro binding studies excluded a binding defect of apoE4Freiburg, and in vivo studies excluded an abnormal accumulation of chylomicron remnants. ApoE4Freiburg and apoE4 accumulated to a similar extent in triglyceride-rich lipoproteins. HDLs, however, contained about 40% less apoE4Freiburg than apoE4. In conclusion, our data indicate that apoE4Freiburg exerts its possible atherogenic properties by affecting the metabolism of triglyceride-rich lipoproteins and HDL.


Key Words: apoE polymorphism • mutation • atherosclerosis • isoelectric focusing




This article has been cited by other articles:


Home page
JAMAHome page
A. M. Bennet, E. Di Angelantonio, Z. Ye, F. Wensley, A. Dahlin, A. Ahlbom, B. Keavney, R. Collins, B. Wiman, U. de Faire, et al.
Association of Apolipoprotein E Genotypes With Lipid Levels and Coronary Risk
JAMA, September 19, 2007; 298(11): 1300 - 1311.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
Y. Song, M. J. Stampfer, and S. Liu
Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease
Ann Intern Med, July 20, 2004; 141(2): 137 - 147.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. H. McDermott, J. P.J. Halcox, W. H. Schenke, M. A. Waclawiw, M. N. Merrell, N. Epstein, A. A. Quyyumi, and P. M. Murphy
Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis
Circ. Res., August 31, 2001; 89(5): 401 - 407.
[Abstract] [Full Text] [PDF]